Down-regulation of SIRT3 promotes ovarian carcinoma metastasis

Xue-Cai Dong1, Li-Min Jing2, Wen-Xiang Wang1

  • 1Department of Genycologic Oncology (Section 1), Xinxiang Central Hospital, Xinxiang, Henan, PR China.

Insights

Sirtuin-3 (SIRT3) suppresses ovarian cancer (OC) metastasis by down-regulating Twist. Lower SIRT3 levels enhance OC cell migration, invasion, and liver metastasis, revealing a novel SIRT3/Twist axis for therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian carcinoma (OC) metastasis remains a primary cause of treatment failure.
  • The role of Sirtuin-3 (SIRT3) in OC metastasis is not well understood.
  • SIRT3, a histone deacetylase, has varied roles depending on cell and tumor types.

Purpose of the Study:

  • To investigate the function and mechanism of SIRT3 in ovarian cancer metastasis.
  • To determine the relationship between SIRT3 expression and OC metastatic potential.
  • To elucidate the molecular pathway involving SIRT3 in OC metastasis.

Main Methods:

  • Analysis of SIRT3 expression in metastatic OC tissues and cell lines.
  • In vitro and in vivo assays to assess the impact of SIRT3 modulation on cancer cell migration, invasion, and metastasis.
  • Investigation of the epithelial-to-mesenchymal transition (EMT) pathway and the role of Twist.
  • Detection of the interaction between SIRT3 and Twist.

Main Results:

  • SIRT3 expression was significantly downregulated in metastatic OC tissues and highly metastatic cell lines.
  • SIRT3 knockdown enhanced OC cell migration, invasion, and liver metastasis.
  • SIRT3 overexpression suppressed OC cell metastatic capabilities.
  • SIRT3 inhibits EMT by down-regulating Twist, with a detected interaction between SIRT3 and Twist.

Conclusions:

  • SIRT3 plays a critical suppressive role in ovarian cancer metastasis.
  • The novel SIRT3/Twist axis regulates OC cell metastasis by inhibiting EMT.
  • This SIRT3/Twist axis represents a potential therapeutic target for treating metastatic OC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K